Skip to main content
. 2024 May 31;11(6):ofae304. doi: 10.1093/ofid/ofae304

Table 1.

Characteristics of Participants Included in Analyses

Characteristic Participants, No. (%)
Included in DPSO
(n = 146)
Included in DPE
(n = 96)
Symptomatic 146 (100.0) 85 (88.5)
No. of previous infections
 0 129 (88.4) 85 (88.5)
 1 14 (9.6) 9 (9.4)
 ≥2 3 (2.1) 2 (2.1)
Age
 <18 y 22 (15.1) 17 (17.7)
 18–44 y 91 (62.3) 52 (54.2)
 45–64 y 29 (19.9) 24 (25.0)
 ≥65 y 4 (2.7) 3 (3.1)
Sex
 Male 47 (32.2) 37 (38.5)
 Female 94 (64.4) 58 (60.4)
 Missing 5 (3.4) 1 (1.0)
Race
 White 116 (79.5) 81 (84.4)
 Asian 7 (4.8) 3 (3.1)
 Black/African-American 8 (5.5) 4 (4.2)
 Multiracial 8 (5.5) 3 (3.1)
 Other 4 (2.8) 5 (5.2)
 Missing 3 (2.1) 0 (0.0)
Hispanic 18 (12.3) 6 (6.2)
Educational level
 Bachelor's degree or higher 65 (44.5) 47 (49.0)
 Some college 31 (21.2) 18 (18.8)
 High school graduate 23 (15.8) 15 (15.6)
 Did not finish high school 22 (15.1) 13 (13.5)
 Don’t know 0 (0.0) 3 (3.1)
 Missing 5 (3.4) 0 (0.0)
Vaccination status
 Unvaccinated 47 (32.2) 32 (33.3)
 1 vaccine dose 6 (4.1) 3 (3.1)
 ≥2 vaccine doses 93 (63.7) 61 (63.5)
SARS-CoV-2 variant
 Delta 34 (23.3) 15 (15.6)
 Omicron 101 (69.2) 75 (78.1)
 Unknown 11 (7.5) 6 (6.2)

Abbreviation: DPE, day past exposure; DPSO, day past symptom onset; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.